维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Reome"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Invivo persistence of CD8+polarized T cell subsets producing type 1 or type 2 cytokine显示文摘	Gerwenka A Carter LL Reome JB	1998	J Immunol1998，161，1：	1
2	Tcl7, a unique subset of CD8 T cells that can protect against lethal influenza challenge显示文摘	Hamada H Garcia-Hernandez Mde L Reome JB et ol	2009	J Immunol2009，182，6：	1
3	Tcl7, a unique subset of CD8 T cells that can protect against lethal influenza challenge 显示文摘	Hamada H Garcia-Hemandez MdeL Reome JB	2009	J Immuno12009，182，6：	1
4	Te17, a unique subset of CD8 T cells that can protect against lethal influenza challenge 显示文摘	Hamada H Gareia Hernandez Mde L Reome JB	2009	J Immunol2009，182，6：	1
5	Tcl and Tc2 effector cell therapy elicit long term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses显示文摘	Dobrzanski M J Reome J B Hollenbaugh J A etal	2004	J Immunol2004，172，3：	1
6	Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancer显示文摘	Reome JB Hylind JC Dutton RW	2004	Clin Immuno2004，111，1：	1
7	Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancer显示文摘	Reome JB Hylind JC Dutton RW	2004	Clin Immunol2004，111，1：	1
8	Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancer显示文摘	Reome JB Ylind JC Dutton RW	2004	Clin Immunol2004，111，1：	1
9	Immunopotentiating role of IFN-γ in early and late stages of type 1 CD8 effector cell-mediated tumor rejection显示文摘	Dobrzanski MJ Reome JB Dutton RW	2001	Clinical Immunology2001，98，1：	1
10	Tel and Te2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses显示文摘	Dobrzanski MJ Reome JB Hollenbangh JA	2004	J Immunol2004，172，3：	1
11	Immunopotentiating role of IFN - ',/ in early and late stages of type 1 CD8 effector cell - mediated tumor rejection 显示文摘	Dobrzanski M J Reome J B Dutton R W	2001	Clin Immunol2001，98，1：	1
12	In vivo persis- tence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines显示文摘	Cerwenka A Carter LL Reome JB	1998	J Immunol1998，161，1：	1
13	Type 1 and type 2 tumor infiltrating efector cell subpopulations in progressive breast cancer 显示文摘	Reome JB ylind JC Dutton RW	2004	Clin Immunol2004，111，1：	1
14	Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge显示文摘	Hamada H de la Luz Garcia-Hernandez M Reome J B Misra S K Strutt T M McKinstry K K Cooper A M Swain S L Dutton R W	2009	J Immunol2009，182，6：	1
15	Type 1 and type 2 tumor infiltrating effeetor cell subpopulations in progressive breast cancer 显示文摘	Reome JB Hylind JC Dutton RW	2004	Clin Immunol2004，111，1：	1
16	Adoptive transfer of tumor - specific Tel7 effector T cells controls the growth of B16 melanoma in mice 显示文摘	Gareia - Hemandez Mde L Hamada H Reome JB	2010	Immunol2010，184，8：	1
17	Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancer 显示文摘	Reome JB Hylind JC Dutton RW	2004	Clin Immunol2004，111，1：	1
18	Tcl and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses显示文摘	Dobrzanski MJ Reome JB Hollenbaugh JA		0，，03：	1
19	Tcl7, a unique subset of CD8+T cells that can protect against lethal influenza chal- lenge 显示文摘	Hamada H Garcia-Hernandez M D Reome J B	2009	J Immunol2009，182，6：	1
20	In vivo persistence of CD8^+ polarized T cell subsets producing type 1 or type 2 cytokine 显示文摘	Gerwenka A Carter LL Reome B	1998	J Immunol1998，161，1：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示